Hims & Hers Health [HIMS] vs Procter & Gamble [PG] Detailed Stock Comparison

Hims & Hers Health

NYSE
Loading...

Procter & Gamble

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Hims & Hers Health wins in 4 metrics, Procter & Gamble wins in 15 metrics, with 0 ties. Procter & Gamble appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricHims & Hers HealthProcter & GambleBetter
P/E Ratio (TTM)73.1923.97Procter & Gamble
Price-to-Book Ratio23.207.13Procter & Gamble
Debt-to-Equity Ratio185.6069.86Procter & Gamble
PEG Ratio0.3421.03Hims & Hers Health
EV/EBITDA80.9716.09Procter & Gamble
Profit Margin (TTM)9.61%18.95%Procter & Gamble
Operating Margin (TTM)4.91%25.15%Procter & Gamble
EBITDA Margin (TTM)4.91%25.15%Procter & Gamble
Return on Equity41.88%31.24%Hims & Hers Health
Return on Assets (TTM)6.94%10.91%Procter & Gamble
Free Cash Flow (TTM)$198.33M$14.04BProcter & Gamble
Dividend YieldN/A1.92%N/A
1-Year Return199.66%-12.18%Hims & Hers Health
Price-to-Sales Ratio (TTM)6.494.33Procter & Gamble
Enterprise Value$12.97B$393.52BProcter & Gamble
EV/Revenue Ratio6.444.67Procter & Gamble
Gross Profit Margin (TTM)76.39%49.11%Hims & Hers Health
Revenue per Share (TTM)$9$36Procter & Gamble
Earnings per Share (Diluted)$0.79$6.51Procter & Gamble
Beta (Stock Volatility)2.140.36Procter & Gamble
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Hims & Hers Health vs Procter & Gamble Stock Performance Analysis

Loading Price Chart...

Hims & Hers Health
Procter & Gamble
Hims & Hers Health Stock Overview | Procter & Gamble Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Hims & Hers Health3.04%5.76%23.87%23.98%42.34%111.31%
Procter & Gamble-0.18%-4.93%-2.39%-4.95%-7.99%-8.17%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Hims & Hers Health199.66%854.30%406.66%443.37%443.37%443.37%
Procter & Gamble-12.18%20.73%10.35%110.47%153.36%156.34%

News Based Sentiment: Hims & Hers Health vs Procter & Gamble

Hims & Hers Health

News based Sentiment: MIXED

September presented a mixed bag for Hims & Hers, with positive developments like the men's health expansion and strong stock performance countered by FDA scrutiny and insider selling. These conflicting signals create a complex investment picture, making it a significant month for the company's trajectory.

View Hims & Hers Health News Sentiment Analysis

Procter & Gamble

News based Sentiment: MIXED

September presented a mixed bag for P&G, with an initial earnings miss and stock decline followed by a strong Q4 performance and positive guidance. This combination of challenges and successes makes it a significant month for investors, requiring a nuanced assessment of the company's prospects.

View Procter & Gamble News Sentiment Analysis

Performance & Financial Health Analysis: Hims & Hers Health vs Procter & Gamble

MetricHIMSPG
Market Information
Market Cap i$12.66B$359.85B
Market Cap CategoryLarge capMega cap
10 Day Avg. Volume i33,409,8107,428,170
90 Day Avg. Volume i27,156,5606,766,390
Last Close$54.87$152.15
52 Week Range$16.05 - $72.98$149.91 - $180.43
% from 52W High-24.82%-15.67%
All-Time High$72.98 (Feb 17, 2025)$180.43 (Nov 25, 2024)
% from All-Time High-24.82%-15.67%
Growth Metrics
Quarterly Revenue Growth0.73%0.02%
Quarterly Earnings Growth2.20%0.15%
Financial Health
Profit Margin (TTM) i0.10%0.19%
Operating Margin (TTM) i0.05%0.25%
Return on Equity (TTM) i0.42%0.31%
Debt to Equity (MRQ) i185.6069.86
Cash & Liquidity
Book Value per Share (MRQ)$2.49$21.88
Cash per Share (MRQ)$5.06$4.08
Operating Cash Flow (TTM) i$261.62M$17.82B
Levered Free Cash Flow (TTM) i$93.82M$11.38B
Dividends
Last 12-Month Dividend Yield iN/A1.92%
Last 12-Month Dividend iN/A$3.03

Valuation & Enterprise Metrics Analysis: Hims & Hers Health vs Procter & Gamble

MetricHIMSPG
Price Ratios
P/E Ratio (TTM) i73.1923.97
Forward P/E i125.7021.03
PEG Ratio i0.3421.03
Price to Sales (TTM) i6.494.33
Price to Book (MRQ) i23.207.13
Market Capitalization
Market Capitalization i$12.66B$359.85B
Enterprise Value i$12.97B$393.52B
Enterprise Value Metrics
Enterprise to Revenue i6.444.67
Enterprise to EBITDA i80.9716.09
Risk & Other Metrics
Beta i2.140.36
Book Value per Share (MRQ) i$2.49$21.88

Financial Statements Comparison: Hims & Hers Health vs Procter & Gamble

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)HIMSPG
Revenue/Sales i$586.01M$20.89B
Cost of Goods Sold i$155.32M$10.63B
Gross Profit i$430.69M$10.26B
Research & Development i$29.91MN/A
Operating Income (EBIT) i$57.90M$4.35B
EBITDA i$66.17M$5.46B
Pre-Tax Income i$60.50M$4.52B
Income Tax i$11.01M$895.00M
Net Income (Profit) i$49.49M$3.63B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)HIMSPG
Cash & Equivalents i$273.74M$9.56B
Total Current Assets i$446.96M$25.39B
Total Current Liabilities i$280.36M$36.06B
Long-Term Debt i$59.65M$25.70B
Total Shareholders Equity i$549.26M$52.28B
Retained Earnings i$-192.65M$129.97B
Property, Plant & Equipment i$129.84M$0

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)HIMSPG
Operating Cash Flow i$122.67M$3.71B
Capital Expenditures i$-55.33MN/A
Free Cash Flow i$50.05M$2.85B
Debt Repayment iN/A$-1.05B
Common Stock Repurchase i$0$-1.35B

Short Interest & Institutional Ownership Analysis

MetricHIMSPG
Shares Short i74.64M17.25M
Short Ratio i2.412.42
Short % of Float i0.41%0.01%
Average Daily Volume (10 Day) i33,409,8107,428,170
Average Daily Volume (90 Day) i27,156,5606,766,390
Shares Outstanding i220.84M2.34B
Float Shares i197.55M2.34B
% Held by Insiders i0.11%0.00%
% Held by Institutions i0.89%0.70%

Dividend Analysis & Yield Comparison: Hims & Hers Health vs Procter & Gamble

MetricHIMSPG
Last 12-Month Dividend iN/A$3.03
Last 12-Month Dividend Yield iN/A1.92%
3-Year Avg Annual Dividend iN/A$3.51
3-Year Avg Dividend Yield iN/A0.63%
3-Year Total Dividends iN/A$10.53
Ex-Dividend DateN/AJan 24, 2025